Evaluate the Intestinal Microbiome in Patients With Erosive Gastroesophageal Reflux Disease and in Asymptomatic Healthy Controls
CompletedOBSERVATIONAL
Enrollment
22
Participants
Timeline
Start Date
May 10, 2017
Primary Completion Date
February 20, 2019
Study Completion Date
February 20, 2019
Conditions
Gastroesophageal Reflux Disease With Esophagitis
Trial Locations (1)
04014-020
Hospital das Clinicas da FMUSP, São Paulo
All Listed Sponsors
lead
University of Sao Paulo General Hospital
OTHER
NCT04248296 - Evaluate the Intestinal Microbiome in Patients With Erosive Gastroesophageal Reflux Disease and in Asymptomatic Healthy Controls | Biotech Hunter | Biotech Hunter